We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Medicure Inc., a cardiovascular focused biopharmaceutical company, announced that the company has acquired the exclusive U.S. rights to AGGRASTAT Injection (tirofiban hydrochloride) from MGI PHARMA, INC.
NexMed, Inc., a developer of innovative treatments based on the NexACT technology, announced that it has confirmed the long term room temperature stability of Alprox-TD, the company's proprietary topical treatment for erectile dysfunction ("ED").
The Washington Legal Foundation, a conservative think tank, has filed a petition with the Food and Drug Administration challenging the FDA's authority to send warning letters to drug companies whose advertising it finds misleading.
The Journal of the American Medical Association said it and other periodicals would be sued by the pharmaceutical industry if they banned authors who fail to reveal financial ties to drug makers.
Drugmaker GlaxoSmithKline Plc. warned on Tuesday that there is an increased risk of cleft lip or cleft palate when the company's antiepileptic drug Lamictal is used during early pregnancy.
German drug company Altana AG and its U.S. distribution partner Wyeth are suing German drug maker Schwarz Pharma AG's U.S. affiliate Kudco, Altana confirmed Wednesday.
Mentholatum announced that it would conduct a nationwide voluntary recall of its WellPatch Cough & Cold Soothing Vapor Pads due to potential serious adverse health effects that could result if children eat the product.
Barr Pharmaceuticals is making a change to its Plan B application that should clear the way for the FDA to approve the contraceptive for OTC use, a Barr spokeswoman said.